Shockwave Medical Inc (SWAV)
330.01
-0.37
(-0.11%)
USD |
NASDAQ |
May 06, 16:00
330.25
+0.24
(+0.07%)
After-Hours: 18:56
Shockwave Medical SG&A Expense (Annual): 330.10M for Dec. 31, 2023
SG&A Expense (Annual) Chart
Historical SG&A Expense (Annual) Data
Date | Value |
---|---|
December 31, 2023 | 330.10M |
December 31, 2022 | 218.92M |
December 31, 2021 | 146.04M |
December 31, 2020 | 75.54M |
Date | Value |
---|---|
December 31, 2019 | 44.75M |
December 31, 2018 | 23.52M |
December 31, 2017 | 11.78M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Annual) Range, Past 5 Years
44.75M
Minimum
2019
330.10M
Maximum
2023
163.07M
Average
146.04M
Median
2021
SG&A Expense (Annual) Benchmarks
Boston Scientific Corp | 5.19B |
AtriCure Inc | 253.14M |
Masimo Corp | 664.00M |
Perspective Therapeutics Inc | 21.06M |
Xtant Medical Holdings Inc | 64.29M |